|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:BNIP3L-XPA (FusionGDB2 ID:9994) |
Fusion Gene Summary for BNIP3L-XPA |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: BNIP3L-XPA | Fusion gene ID: 9994 | Hgene | Tgene | Gene symbol | BNIP3L | XPA | Gene ID | 665 | 7507 |
| Gene name | BCL2 interacting protein 3 like | XPA, DNA damage recognition and repair factor | |
| Synonyms | BNIP3a|NIX | XP1|XPAC | |
| Cytomap | 8p21.2 | 9q22.33 | |
| Type of gene | protein-coding | protein-coding | |
| Description | BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-likeBCL2/adenovirus E1B 19 kDa protein-interacting protein 3ABCL2/adenovirus E1B 19-kd protein-interacting protein 3aBCL2/adenovirus E1B 19kDa interacting protein 3 likeNIP-3-like protein XNIP3 | DNA repair protein complementing XP-A cellsxeroderma pigmentosum group A-complementing proteinxeroderma pigmentosum, complementation group A | |
| Modification date | 20200313 | 20200322 | |
| UniProtAcc | O60238 | . | |
| Ensembl transtripts involved in fusion gene | ENST00000521254, ENST00000380629, ENST00000518611, ENST00000520409, ENST00000523515, | ENST00000375128, ENST00000485042, | |
| Fusion gene scores | * DoF score | 7 X 7 X 2=98 | 5 X 5 X 2=50 |
| # samples | 9 | 5 | |
| ** MAII score | log2(9/98*10)=-0.122856747785533 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(5/50*10)=0 | |
| Context | PubMed: BNIP3L [Title/Abstract] AND XPA [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | BNIP3L(26265892)-XPA(100437869), # samples:1 | ||
| Anticipated loss of major functional domain due to fusion event. | |||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Hgene | BNIP3L | GO:0043065 | positive regulation of apoptotic process | 9973195 |
| Hgene | BNIP3L | GO:0043066 | negative regulation of apoptotic process | 10381623 |
| Hgene | BNIP3L | GO:0051607 | defense response to virus | 9973195 |
| Tgene | XPA | GO:0006281 | DNA repair | 1601884 |
| Tgene | XPA | GO:0009650 | UV protection | 1601884 |
| Fusion gene breakpoints across BNIP3L (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across XPA (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | KIRC | TCGA-BP-4344-01A | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
Top |
Fusion Gene ORF analysis for BNIP3L-XPA |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 3UTR-3CDS | ENST00000521254 | ENST00000375128 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| 3UTR-5UTR | ENST00000521254 | ENST00000485042 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| 5CDS-5UTR | ENST00000380629 | ENST00000485042 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| 5CDS-5UTR | ENST00000518611 | ENST00000485042 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| 5CDS-5UTR | ENST00000520409 | ENST00000485042 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| 5CDS-5UTR | ENST00000523515 | ENST00000485042 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| In-frame | ENST00000380629 | ENST00000375128 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| In-frame | ENST00000518611 | ENST00000375128 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| In-frame | ENST00000520409 | ENST00000375128 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| In-frame | ENST00000523515 | ENST00000375128 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000380629 | BNIP3L | chr8 | 26265892 | + | ENST00000375128 | XPA | chr9 | 100437869 | - | 1523 | 844 | 71 | 904 | 277 |
| ENST00000523515 | BNIP3L | chr8 | 26265892 | + | ENST00000375128 | XPA | chr9 | 100437869 | - | 1291 | 612 | 19 | 672 | 217 |
| ENST00000520409 | BNIP3L | chr8 | 26265892 | + | ENST00000375128 | XPA | chr9 | 100437869 | - | 1272 | 593 | 12 | 653 | 213 |
| ENST00000518611 | BNIP3L | chr8 | 26265892 | + | ENST00000375128 | XPA | chr9 | 100437869 | - | 1346 | 667 | 176 | 727 | 183 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000380629 | ENST00000375128 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - | 0.001758601 | 0.9982414 |
| ENST00000523515 | ENST00000375128 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - | 0.003772226 | 0.99622774 |
| ENST00000520409 | ENST00000375128 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - | 0.004320527 | 0.99567956 |
| ENST00000518611 | ENST00000375128 | BNIP3L | chr8 | 26265892 | + | XPA | chr9 | 100437869 | - | 0.006152366 | 0.99384767 |
Top |
Fusion Genomic Features for BNIP3L-XPA |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for BNIP3L-XPA |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr8:26265892/chr9:100437869) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| BNIP3L | . |
| FUNCTION: Induces apoptosis. Interacts with viral and cellular anti-apoptosis proteins. Can overcome the suppressors BCL-2 and BCL-XL, although high levels of BCL-XL expression will inhibit apoptosis. Inhibits apoptosis induced by BNIP3. Involved in mitochondrial quality control via its interaction with SPATA18/MIEAP: in response to mitochondrial damage, participates in mitochondrial protein catabolic process (also named MALM) leading to the degradation of damaged proteins inside mitochondria. The physical interaction of SPATA18/MIEAP, BNIP3 and BNIP3L/NIX at the mitochondrial outer membrane regulates the opening of a pore in the mitochondrial double membrane in order to mediate the translocation of lysosomal proteins from the cytoplasm to the mitochondrial matrix. May function as a tumor suppressor. {ECO:0000269|PubMed:10381623, ECO:0000269|PubMed:21264228}. | FUNCTION: Transcriptional activator which is required for calcium-dependent dendritic growth and branching in cortical neurons. Recruits CREB-binding protein (CREBBP) to nuclear bodies. Component of the CREST-BRG1 complex, a multiprotein complex that regulates promoter activation by orchestrating a calcium-dependent release of a repressor complex and a recruitment of an activator complex. In resting neurons, transcription of the c-FOS promoter is inhibited by BRG1-dependent recruitment of a phospho-RB1-HDAC1 repressor complex. Upon calcium influx, RB1 is dephosphorylated by calcineurin, which leads to release of the repressor complex. At the same time, there is increased recruitment of CREBBP to the promoter by a CREST-dependent mechanism, which leads to transcriptional activation. The CREST-BRG1 complex also binds to the NR2B promoter, and activity-dependent induction of NR2B expression involves a release of HDAC1 and recruitment of CREBBP (By similarity). {ECO:0000250}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | BNIP3L | chr8:26265892 | chr9:100437869 | ENST00000380629 | + | 5 | 6 | 126_148 | 203 | 220.0 | Motif | Note=BH3 |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | BNIP3L | chr8:26265892 | chr9:100437869 | ENST00000380629 | + | 5 | 6 | 188_208 | 203 | 220.0 | Transmembrane | Helical |
| Tgene | XPA | chr8:26265892 | chr9:100437869 | ENST00000375128 | 4 | 6 | 78_84 | 224 | 274.0 | Compositional bias | Note=Poly-Glu | |
| Tgene | XPA | chr8:26265892 | chr9:100437869 | ENST00000375128 | 4 | 6 | 26_47 | 224 | 274.0 | Motif | Nuclear localization signal | |
| Tgene | XPA | chr8:26265892 | chr9:100437869 | ENST00000375128 | 4 | 6 | 105_129 | 224 | 274.0 | Zinc finger | . |
Top |
Fusion Gene Sequence for BNIP3L-XPA |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >9994_9994_1_BNIP3L-XPA_BNIP3L_chr8_26265892_ENST00000380629_XPA_chr9_100437869_ENST00000375128_length(transcript)=1523nt_BP=844nt GCGCGTCAGCCTGACTCGAGCGTCTCCACGTCCGGGGCCCGCAGGGGAGCGCCCCTGCCCCGTCCGGTCGCTTGTTGTGTTGTCATCACG TGGCCTGGGCGGGCCCTGACGTCAGGGGCAGGGGAGGGACGGCGCAGGCGCAGAAAAGGGGGCGGCGGACTCGGCTTGTTGTGTTGCTGC CTGAGTGCCGGAGACGGTCCTGCTGCTGCCGCAGTCCTGCCAGCTGTCCGACAATGTCGTCCCACCTAGTCGAGCCGCCGCCGCCCCTGC ACAACAACAACAACAACTGCGAGGAAAATGAGCAGTCTCTGCCCCCGCCGGCCGGCCTCAACAGTTCCTGGGTGGAGCTACCCATGAACA GCAGCAATGGCAATGATAATGGCAATGGGAAAAATGGGGGGCTGGAACACGTACCATCCTCATCCTCCATCCACAATGGAGACATGGAGA AGATTCTTTTGGATGCACAACATGAATCAGGACAGAGTAGTTCCAGAGGCAGTTCTCACTGTGACAGCCCTTCGCCACAAGAAGATGGGC AGATCATGTTTGATGTGGAAATGCACACCAGCAGGGACCATAGCTCTCAGTCAGAAGAAGAAGTTGTAGAAGGAGAGAAGGAAGTCGAGG CTTTGAAGAAAAGTGCGGACTGGGTATCAGACTGGTCCAGTAGACCCGAAAACATTCCACCCAAGGAGTTCCACTTCAGACACCCTAAAC GTTCTGTGTCTTTAAGCATGAGGAAAAGTGGAGCCATGAAGAAAGGGGGTATTTTCTCCGCAGAATTTCTGAAGGTGTTCATTCCATCTC TCTTCCTTTCTCATGTTTTGGCTTTGGGGCTAGGAATTGCGGCGAGCAGTAAGAAGCAGCGTGTGGAAAAGGGAGACGATTGTTCATCAA CATGAGTATGGACCAGAAGAAAACCTAGAAGATGACATGTACCGTAAGACTTGTACTATGTGTGGCCATGAACTGACATATGAAAAAATG TGATTTTTTAGTTCAGTGACCTGTTTTATAGAATTTTATATTTAAATAAAGGAAATTTAGATTGGTCCTTTTCAAAATTCAAAAAAAAAA GCAACATCTTCATAGATGAATGAAACCCTTGTATAAGTAATACTTCAGTAATAATTATGTATGTTATGGCTTAAAAGCAAGTTTCAGTGA AGGTCACCTGGCCTGGTTGTGTGCACAATGTCATGTCTGTGATTGCCTTCTTACAACAGAGATGGGAGCTGAGTGCTAGAGTAGGTGCAG AAGTGGTAGGTCAGCTACAAATTTGAGGACAAGATACCAAGGCAAACCCTAGATTGGGGTAGAGGGAAAAGGGTTCAACAAAGGCTGAAC TGGATTCTTAACCAAGAAACAAATAATAGCAATGGTGGTGCACCACTGTACCCCAGGTTCTAGTCATGTGTTTTTTAGGACGATTTCTGT >9994_9994_1_BNIP3L-XPA_BNIP3L_chr8_26265892_ENST00000380629_XPA_chr9_100437869_ENST00000375128_length(amino acids)=277AA_BP=251 MLCCHHVAWAGPDVRGRGGTAQAQKRGRRTRLVVLLPECRRRSCCCRSPASCPTMSSHLVEPPPPLHNNNNNCEENEQSLPPPAGLNSSW VELPMNSSNGNDNGNGKNGGLEHVPSSSSIHNGDMEKILLDAQHESGQSSSRGSSHCDSPSPQEDGQIMFDVEMHTSRDHSSQSEEEVVE GEKEVEALKKSADWVSDWSSRPENIPPKEFHFRHPKRSVSLSMRKSGAMKKGGIFSAEFLKVFIPSLFLSHVLALGLGIAASSKKQRVEK -------------------------------------------------------------- >9994_9994_2_BNIP3L-XPA_BNIP3L_chr8_26265892_ENST00000518611_XPA_chr9_100437869_ENST00000375128_length(transcript)=1346nt_BP=667nt GTGGCTCCACCCCTTCAACTTTTTGTCCAAGAAAACTTTTCGTGTTTGCCTGTAGCTGATGTGCAGTTGTTTCTGCTCCCAAATCAACAG GGTTTAATGAAAACCCTAGAAAGTAGAAACCCGTGGGAGAGAAAAGAAAAAAGACAAGTTCACAAGGTTCCTGGGTGGAGCTACCCATGA ACAGCAGCAATGGCAATGATAATGGCAATGGGAAAAATGGGGGGCTGGAACACGTACCATCCTCATCCTCCATCCACAATGGAGACATGG AGAAGATTCTTTTGGATGCACAACATGAATCAGGACAGAGTAGTTCCAGAGGCAGTTCTCACTGTGACAGCCCTTCGCCACAAGAAGATG GGCAGATCATGTTTGATGTGGAAATGCACACCAGCAGGGACCATAGCTCTCAGTCAGAAGAAGAAGTTGTAGAAGGAGAGAAGGAAGTCG AGGCTTTGAAGAAAAGTGCGGACTGGGTATCAGACTGGTCCAGTAGACCCGAAAACATTCCACCCAAGGAGTTCCACTTCAGACACCCTA AACGTTCTGTGTCTTTAAGCATGAGGAAAAGTGGAGCCATGAAGAAAGGGGGTATTTTCTCCGCAGAATTTCTGAAGGTGTTCATTCCAT CTCTCTTCCTTTCTCATGTTTTGGCTTTGGGGCTAGGAATTGCGGCGAGCAGTAAGAAGCAGCGTGTGGAAAAGGGAGACGATTGTTCAT CAACATGAGTATGGACCAGAAGAAAACCTAGAAGATGACATGTACCGTAAGACTTGTACTATGTGTGGCCATGAACTGACATATGAAAAA ATGTGATTTTTTAGTTCAGTGACCTGTTTTATAGAATTTTATATTTAAATAAAGGAAATTTAGATTGGTCCTTTTCAAAATTCAAAAAAA AAAGCAACATCTTCATAGATGAATGAAACCCTTGTATAAGTAATACTTCAGTAATAATTATGTATGTTATGGCTTAAAAGCAAGTTTCAG TGAAGGTCACCTGGCCTGGTTGTGTGCACAATGTCATGTCTGTGATTGCCTTCTTACAACAGAGATGGGAGCTGAGTGCTAGAGTAGGTG CAGAAGTGGTAGGTCAGCTACAAATTTGAGGACAAGATACCAAGGCAAACCCTAGATTGGGGTAGAGGGAAAAGGGTTCAACAAAGGCTG AACTGGATTCTTAACCAAGAAACAAATAATAGCAATGGTGGTGCACCACTGTACCCCAGGTTCTAGTCATGTGTTTTTTAGGACGATTTC >9994_9994_2_BNIP3L-XPA_BNIP3L_chr8_26265892_ENST00000518611_XPA_chr9_100437869_ENST00000375128_length(amino acids)=183AA_BP=157 MNSSNGNDNGNGKNGGLEHVPSSSSIHNGDMEKILLDAQHESGQSSSRGSSHCDSPSPQEDGQIMFDVEMHTSRDHSSQSEEEVVEGEKE VEALKKSADWVSDWSSRPENIPPKEFHFRHPKRSVSLSMRKSGAMKKGGIFSAEFLKVFIPSLFLSHVLALGLGIAASSKKQRVEKGDDC -------------------------------------------------------------- >9994_9994_3_BNIP3L-XPA_BNIP3L_chr8_26265892_ENST00000520409_XPA_chr9_100437869_ENST00000375128_length(transcript)=1272nt_BP=593nt CTCTGTTGCCTCCTGGGGTCTTGGGCCCGGGGCCGTTTGGGCTCGCGGTCCGGGAGCGGCGCGGGTAGCGCGGATCCCCCTGGTTCCTGG GTGGAGCTACCCATGAACAGCAGCAATGGCAATGATAATGGCAATGGGAAAAATGGGGGGCTGGAACACGTACCATCCTCATCCTCCATC CACAATGGAGACATGGAGAAGATTCTTTTGGATGCACAACATGAATCAGGACAGAGTAGTTCCAGAGGCAGTTCTCACTGTGACAGCCCT TCGCCACAAGAAGATGGGCAGATCATGTTTGATGTGGAAATGCACACCAGCAGGGACCATAGCTCTCAGTCAGAAGAAGAAGTTGTAGAA GGAGAGAAGGAAGTCGAGGCTTTGAAGAAAAGTGCGGACTGGGTATCAGACTGGTCCAGTAGACCCGAAAACATTCCACCCAAGGAGTTC CACTTCAGACACCCTAAACGTTCTGTGTCTTTAAGCATGAGGAAAAGTGGAGCCATGAAGAAAGGGGGTATTTTCTCCGCAGAATTTCTG AAGGTGTTCATTCCATCTCTCTTCCTTTCTCATGTTTTGGCTTTGGGGCTAGGAATTGCGGCGAGCAGTAAGAAGCAGCGTGTGGAAAAG GGAGACGATTGTTCATCAACATGAGTATGGACCAGAAGAAAACCTAGAAGATGACATGTACCGTAAGACTTGTACTATGTGTGGCCATGA ACTGACATATGAAAAAATGTGATTTTTTAGTTCAGTGACCTGTTTTATAGAATTTTATATTTAAATAAAGGAAATTTAGATTGGTCCTTT TCAAAATTCAAAAAAAAAAGCAACATCTTCATAGATGAATGAAACCCTTGTATAAGTAATACTTCAGTAATAATTATGTATGTTATGGCT TAAAAGCAAGTTTCAGTGAAGGTCACCTGGCCTGGTTGTGTGCACAATGTCATGTCTGTGATTGCCTTCTTACAACAGAGATGGGAGCTG AGTGCTAGAGTAGGTGCAGAAGTGGTAGGTCAGCTACAAATTTGAGGACAAGATACCAAGGCAAACCCTAGATTGGGGTAGAGGGAAAAG GGTTCAACAAAGGCTGAACTGGATTCTTAACCAAGAAACAAATAATAGCAATGGTGGTGCACCACTGTACCCCAGGTTCTAGTCATGTGT TTTTTAGGACGATTTCTGTCTCCACGATGGTGGAAACAGTGGGGAACTACTGCTGGAAAAAGCCCTAATAGCAGAAATAAACATTGAGTT >9994_9994_3_BNIP3L-XPA_BNIP3L_chr8_26265892_ENST00000520409_XPA_chr9_100437869_ENST00000375128_length(amino acids)=213AA_BP=187 MGSWARGRLGSRSGSGAGSADPPGSWVELPMNSSNGNDNGNGKNGGLEHVPSSSSIHNGDMEKILLDAQHESGQSSSRGSSHCDSPSPQE DGQIMFDVEMHTSRDHSSQSEEEVVEGEKEVEALKKSADWVSDWSSRPENIPPKEFHFRHPKRSVSLSMRKSGAMKKGGIFSAEFLKVFI -------------------------------------------------------------- >9994_9994_4_BNIP3L-XPA_BNIP3L_chr8_26265892_ENST00000523515_XPA_chr9_100437869_ENST00000375128_length(transcript)=1291nt_BP=612nt CTGTCAAGAGGAGGGGCGCCTGCCTTGCTCCGGGCCTCTCTGTTGCCTCCTGGGGTCTTGGGCCCGGGGCCGTTTGGGCTCGCGGTCCGG GAGCGGCGCGGGTTCCTGGGTGGAGCTACCCATGAACAGCAGCAATGGCAATGATAATGGCAATGGGAAAAATGGGGGGCTGGAACACGT ACCATCCTCATCCTCCATCCACAATGGAGACATGGAGAAGATTCTTTTGGATGCACAACATGAATCAGGACAGAGTAGTTCCAGAGGCAG TTCTCACTGTGACAGCCCTTCGCCACAAGAAGATGGGCAGATCATGTTTGATGTGGAAATGCACACCAGCAGGGACCATAGCTCTCAGTC AGAAGAAGAAGTTGTAGAAGGAGAGAAGGAAGTCGAGGCTTTGAAGAAAAGTGCGGACTGGGTATCAGACTGGTCCAGTAGACCCGAAAA CATTCCACCCAAGGAGTTCCACTTCAGACACCCTAAACGTTCTGTGTCTTTAAGCATGAGGAAAAGTGGAGCCATGAAGAAAGGGGGTAT TTTCTCCGCAGAATTTCTGAAGGTGTTCATTCCATCTCTCTTCCTTTCTCATGTTTTGGCTTTGGGGCTAGGAATTGCGGCGAGCAGTAA GAAGCAGCGTGTGGAAAAGGGAGACGATTGTTCATCAACATGAGTATGGACCAGAAGAAAACCTAGAAGATGACATGTACCGTAAGACTT GTACTATGTGTGGCCATGAACTGACATATGAAAAAATGTGATTTTTTAGTTCAGTGACCTGTTTTATAGAATTTTATATTTAAATAAAGG AAATTTAGATTGGTCCTTTTCAAAATTCAAAAAAAAAAGCAACATCTTCATAGATGAATGAAACCCTTGTATAAGTAATACTTCAGTAAT AATTATGTATGTTATGGCTTAAAAGCAAGTTTCAGTGAAGGTCACCTGGCCTGGTTGTGTGCACAATGTCATGTCTGTGATTGCCTTCTT ACAACAGAGATGGGAGCTGAGTGCTAGAGTAGGTGCAGAAGTGGTAGGTCAGCTACAAATTTGAGGACAAGATACCAAGGCAAACCCTAG ATTGGGGTAGAGGGAAAAGGGTTCAACAAAGGCTGAACTGGATTCTTAACCAAGAAACAAATAATAGCAATGGTGGTGCACCACTGTACC CCAGGTTCTAGTCATGTGTTTTTTAGGACGATTTCTGTCTCCACGATGGTGGAAACAGTGGGGAACTACTGCTGGAAAAAGCCCTAATAG >9994_9994_4_BNIP3L-XPA_BNIP3L_chr8_26265892_ENST00000523515_XPA_chr9_100437869_ENST00000375128_length(amino acids)=217AA_BP=191 MPCSGPLCCLLGSWARGRLGSRSGSGAGSWVELPMNSSNGNDNGNGKNGGLEHVPSSSSIHNGDMEKILLDAQHESGQSSSRGSSHCDSP SPQEDGQIMFDVEMHTSRDHSSQSEEEVVEGEKEVEALKKSADWVSDWSSRPENIPPKEFHFRHPKRSVSLSMRKSGAMKKGGIFSAEFL -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for BNIP3L-XPA |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| Tgene | XPA | chr8:26265892 | chr9:100437869 | ENST00000375128 | 4 | 6 | 4_97 | 224.33333333333334 | 274.0 | CEP164 and required for UV resistance |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for BNIP3L-XPA |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for BNIP3L-XPA |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies